Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation, Gastroenterology, vol.152, issue.5, pp.1090-1099, 2017. ,
, Snapshot, 2017.
New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives, Gut, vol.61, issue.1, pp.36-46, 2012. ,
Grazoprevir-elbasvir combination therapy for treatment-naive cirrhotic and noncirrhotic patients with chronic hepatitis C virus genotype 1, 4, or 6 infection: a randomized trial, Annals of Internal Medicine, vol.163, issue.1, pp.1-13, 2015. ,
Hepatitis B and C in African Americans: Current status and continued challenges, Clinical Gastroenterology and Hepatology, vol.12, issue.5, pp.738-748, 2014. ,
Viral hepatitis in resource-limited countries and access to antiviral therapies: Current and future challenges, Future Virology, vol.8, issue.4, pp.371-380, 2013. ,
National Estimates of Marijuana Use and Related Indicators -National Survey on Drug Use and Health, MMWR Surveillance Summaries, vol.65, issue.11, pp.1-28, 2002. ,
Endocannabinoids and liver disease -Review, Liver International, vol.25, issue.5, pp.921-926, 2005. ,
Elevated levels of endocannabinoids in chronic hepatitis c may modulate cellular immune response and hepatic stellate cell activation, International Journal of Molecular Sciences, vol.16, issue.4, pp.7057-7076, 2015. ,
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study, PLoS ONE, vol.12, issue.4, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01538556
Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease, Liver International, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01854633
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C, Hepatology, vol.42, issue.1, pp.63-71, 2005. ,
Daily cannabis Use: a novel risk factor of steatosis severity in patients with chronic hepatitis C, Gastroenterology, vol.134, issue.2, pp.432-439, 2008. ,
Influence of Cannabis Use on Severity of Hepatitis C Disease, Clinical Gastroenterology and Hepatology, vol.6, issue.1, pp.69-75, 2008. ,
Marijuana smoking does not accelerate progression of liver disease in HIVhepatitis C coinfection: A longitudinal Cohort analysis, Clinical Infectious Diseases, vol.57, issue.5, pp.663-670, 2013. ,
Marijuana Use in Hepatitis C Infection does not Affect Liver Biopsy Histology or Treatment Outcomes, Canadian Journal of Gastroenterology and Hepatology, vol.28, 2014. ,
Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/ Hepatitis C Virus-coinfected Women, Clin Infect Dis, vol.63, issue.4, pp.512-518, 2016. ,
Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH), Journal of Viral Hepatitis, vol.25, issue.2, pp.171-179, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02146848
Potential of cannabidiol for the treatment of viral hepatitis, Pharmacognosy Research, vol.9, issue.1, pp.116-118, 2017. ,
, Citations for HCUP Databases and Tools, 2017.
Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States, Journal of Viral Hepatitis, vol.22, issue.2, pp.137-145, 2015. ,
Hepatitis C/HIV co-infection is associated with higher mortality in hospitalized patients with Hepatitis C or HIV, Journal of Viral Hepatitis, vol.17, issue.10, pp.720-729, 2010. ,
HBV infection is associated with greater mortality in hospitalised patients compared to HCV infection or alcoholic liver disease, Alimentary Pharmacology & Therapeutics, vol.41, issue.10, pp.928-938, 2015. ,
Cirrhosis Is Associated with Increased Mortality in Patients with Diverticulitis: A Nationwide Cross-Sectional Study, Digestive Diseases and Sciences, vol.62, issue.11, pp.3149-3155, 2017. ,
Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study, Clinical Gastroenterology and Hepatology, vol.8, issue.9, pp.800-801, 2010. ,
GMATCH SAS macro: computerized matching of cases to controls using the greedy matching algorithm with a fixed number of controls per case, 2015. ,
Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes, European Heart Journal, vol.33, issue.15, pp.1893-1901, 2012. ,
Can We Trust Observational Studies Using Propensity Scores in the Critical Care Literature? A Systematic Comparison with Randomized Clinical Trials, Critical Care Medicine, vol.43, issue.9, pp.1870-1879, 2015. ,
Easy SAS calculations for risk or prevalence ratios and differences, American Journal of Epidemiology, vol.162, issue.3, pp.199-200, 2005. ,
Hepatitis C Virus Induces the Cannabinoid Receptor 1, PLoS ONE, vol.5, issue.9, p.12841, 2010. ,
Antifibrogenic role of the cannabinoid receptor CB2 in the liver, Gastroenterology, vol.128, issue.3, pp.742-755, 2005. ,
Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats, The Journal of Pharmacology and Experimental Therapeutics, vol.324, issue.2, pp.475-483, 2008. ,
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabisderived non-psychotropic cannabinoid, Carcinogenesis, vol.35, issue.12, pp.2787-2797, 2014. ,
A pilot clinical study of ?9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme, British Journal of Cancer, vol.95, issue.2, pp.197-203, 2006. ,
Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database, Cancer Medicine, vol.6, issue.1, pp.320-329, 2017. ,
Cannabis use improves retention and virological outcomes in patients treated for hepatitis C, European Journal of Gastroenterology & Hepatology, vol.18, issue.10, pp.1057-1063, 2006. ,